Prognostic Significance of Lymphovascular Invasion in Radical Cystectomy on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis

Purpose The objective of the present study was to conduct a systematic review and meta-analysis of published literature to appraise the prognostic value of lymphovascular invasion (LVI) in radical cystectomy specimens. Materials and Methods Following the PRISMA statement, PubMed, Cochrane Library, and SCOPUS database were searched from the respective dates of inception until June 2013. Results A total of 21 articles met the eligibility criteria for this systematic review, which included a total of 12,527 patients ranging from 57 to 4,257 per study. LVI was detected in 34.6% in radical cystectomy specimens. LVI was associated with higher pathological T stage and tumor grade, as well as lymph node metastasis. The pooled hazard ratio (HR) was statistically significant for recurrence-free survival (pooled HR, 1.61; 95% confidence interval [CI], 1.26–2.06), cancer-specific survival (pooled HR, 1.67; 95% CI, 1.38–2.01), and overall survival (pooled HR, 1.67; 95% CI, 1.38–2.01), despite the heterogeneity among included studies. On sensitivity analysis, the pooled HRs and 95% CIs were not significantly altered when any one study was omitted. The funnel plot for overall survival demonstrated a certain degree of asymmetry, which showed slight publication bias. Conclusions This meta-analysis indicates that LVI is significantly associated with poor outcome in patients with bladder cancer who underwent radical cystectomy. Adequately designed prospective studies are required to provide the precise prognostic significance of LVI in bladder cancer.

[1]  J. Cheville,et al.  The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. , 2013, The Journal of urology.

[2]  Y. Lotan,et al.  Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. , 2013, European urology.

[3]  C. Kwak,et al.  Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. , 2013, European journal of cancer.

[4]  A. Longatto-Filho,et al.  Low RKIP expression associates with poor prognosis in bladder cancer patients , 2013, Virchows Archiv.

[5]  C. Stief,et al.  Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. , 2012, Gender medicine.

[6]  Y. Horiguchi,et al.  Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy , 2012, International Journal of Clinical Oncology.

[7]  K. Bensalah,et al.  Prognostic factors for upper urinary tract urothelial carcinoma , 2011, Nature Reviews Urology.

[8]  H. Ha,et al.  Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer , 2011, International Urology and Nephrology.

[9]  Casey K. Ng,et al.  Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic‐assisted radical cystectomy , 2011, BJU international.

[10]  Choung-Soo Kim,et al.  Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? , 2011, World Journal of Urology.

[11]  M. Quek,et al.  Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer , 2010, Journal of surgical oncology.

[12]  K. Moon,et al.  Influence of Stage Discrepancy on Outcome in Patients Treated with Radical Cystectomy , 2010, Tumori.

[13]  A. Morselli-Labate,et al.  Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. , 2010, Anticancer research.

[14]  N. Cho,et al.  High-Grade Hydronephrosis Predicts Poor Outcomes After Radical Cystectomy in Patients with Bladder Cancer , 2010, Journal of Korean medical science.

[15]  U. Capitanio,et al.  International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy , 2010, BJU international.

[16]  S. Campbell,et al.  Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. , 2010, Urology.

[17]  D. Querleu,et al.  Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[19]  Ronald B. Moore,et al.  Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database. , 2009, The Journal of urology.

[20]  E. D. de Vries,et al.  Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis , 2009, British Journal of Cancer.

[21]  B. Konety,et al.  The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer , 2009, BJU international.

[22]  K. Bensalah,et al.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Sonnad,et al.  The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis , 2008, BJU international.

[24]  K. Naito,et al.  Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer , 2008, BJU international.

[25]  S. Baba,et al.  Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer. , 2008, Urology.

[26]  F. Montorsi,et al.  Predicting survival after radical cystectomy for bladder cancer , 2008, BJU international.

[27]  W. Hohenberger,et al.  Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. , 2008, International journal of radiation oncology, biology, physics.

[28]  B. Reșorlu,et al.  Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. , 2007, Urology.

[29]  K. Ohba,et al.  Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. , 2006, The Journal of urology.

[30]  E. Kikuchi,et al.  Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. , 2005, The Journal of urology.

[31]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[32]  D G Altman,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British journal of cancer.

[33]  for the Statistics Subcommittee of the NCI—EORTC Worki Diagnostics.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2005, Nature Clinical Practice Oncology.

[34]  C. Cass,et al.  Gastric Cancer: Establishing Predictors of Biologic Behavior with Use of Population-Based Data , 2004, Annals of Surgical Oncology.

[35]  I. Jacobs,et al.  Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry , 2003, Journal of clinical pathology.

[36]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[37]  R. Fimmers,et al.  Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  M. Silverstein,et al.  Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. , 2002, American journal of surgery.

[39]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[40]  L. Ellis,et al.  Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  M. Kattan,et al.  Lymphovascular invasion as a predictor of disease progression in prostate cancer. , 2000, The American journal of surgical pathology.

[42]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[43]  C. Lengeler,et al.  Language bias in randomised controlled trials published in English and German , 1997, The Lancet.

[44]  N. Weidner,et al.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[46]  M. Taron,et al.  BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[48]  M. Jordá,et al.  Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? , 2009, World Journal of Urology.

[49]  PhD Jong-Min Lee MD,et al.  The Risk of Lymph Node Metastasis Based on Myometrial Invasion and Tumor Grade in Endometrioid Uterine Cancers: A Multicenter, Retrospective Korean Study , 2009, Annals of Surgical Oncology.

[50]  L. Akslen,et al.  Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  N. Dubrawsky.  Cancer statistics , 2022 .